Related Experiment Video
Updated: Jun 16, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Acute renal failure under dasatinib therapy
Sultan Ozkurt1, Gokhan Temiz, Mustafa Fuat Acikalin
1Department of Nephrology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Abstract:
Dasatinib is a second-generation tyrosine kinase inhibitor that is approved for the treatment of imatinib-resistant or imatinib-intolerant chronic myeloid leukemia. It has a 325 times stronger in vitro activity against to native BCR-ABL when comparing with imatinib. Little is known about the effects of dasatinib on renal function. A literature review revealed only one case with imatinib-resistant chronic myeloid leukemia that developed renal failure after being placed on dasatinib therapy. Here we report a patient with imatinib-resistant chronic myeloid leukemia who developed gastroenteritis and acute renal failure after a short time from the initiation of dasatinib therapy. After dasatinib interruption, these side effects resolved completely in days. In summary, dasatinib is a potent drug in the treatment of chronic myeloid leukemia, but close clinical monitoring and the timely interruption of the therapy in patients who developed acute renal failure are warranted.
Insights
Dasatinib effectively treats chronic myeloid leukemia but can cause acute renal failure. Promptly interrupting dasatinib therapy is crucial for patient recovery.
Area of Science:
- Oncology
- Pharmacology
- Nephrology
Background:
- Dasatinib is a potent tyrosine kinase inhibitor for imatinib-resistant chronic myeloid leukemia.
- Its effects on renal function are not well-documented.
- Limited data suggests a potential link between dasatinib and renal complications.
Observation:
- A patient with imatinib-resistant chronic myeloid leukemia developed gastroenteritis and acute renal failure shortly after starting dasatinib.
- These adverse events resolved completely upon discontinuation of dasatinib therapy.
- This case highlights a potential adverse effect of dasatinib on kidney function.
Findings:
- Dasatinib, while effective against BCR-ABL, may pose a risk for acute renal failure.
- Gastroenteritis was observed concurrently with renal impairment in this patient.
- Renal function recovery was rapid after dasatinib withdrawal.
Implications:
- Close clinical monitoring of renal function is essential for patients receiving dasatinib.
- Timely interruption of dasatinib therapy may prevent severe renal complications.
- Further research is needed to elucidate the mechanisms of dasatinib-induced nephrotoxicity.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Acute Kidney Injury III: Clinical Manifestations
